Metraipolis › archive › dc_f10dba5aa9db

Targeting glioblastoma with HDAC inhibitors: insights into hydroxamic acid-based therapeutic strategies — Europe PMC PMID:41331688

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41331688
DOI
10.1186/s40478-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T00:38:30.681Z
SHA-256 of the archived text
f4b5e4d733cf225326dc103f41350b6ba538657c1ecf3a006ba7421b0d6ae41e
Stable URL of this page
https://metraipolis.com/documento/dc_f10dba5aa9db

How to cite

Targeting glioblastoma with HDAC inhibitors: insights into hydroxamic acid-based therapeutic strategies — Europe PMC PMID:41331688 — Europe PMC (en), https://europepmc.org/article/MED/41331688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f10dba5aa9db (Metraipolis archive dc_f10dba5aa9db, sha256 f4b5e4d733cf225326dc103f41350b6ba538657c1ecf3a006ba7421b0d6ae41e)
BibTeX
@misc{dcf10dba5aa9db,
  title = {Targeting glioblastoma with HDAC inhibitors: insights into hydroxamic acid-based therapeutic strategies — Europe PMC PMID:41331688},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41331688},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f10dba5aa9db; sha256 f4b5e4d733cf225326dc103f41350b6ba538657c1ecf3a006ba7421b0d6ae41e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41331688. Agents can read the archived copy with the MCP tool read_document.